WithdrawnNCT03141398

Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group

Studying Rare hereditary hemochromatosis

Last synced from ClinicalTrials.gov May 2, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Hamad Medical Corporation
Principal Investigator: Mohamed Yassin
Hamad Medical Corporation
Intervention: Continuous Glucose Monitoring (CGM)(diagnostic_test)
Eligibility: 14 years · All sexes
Timeline: 2017 – 2018

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03141398 on ClinicalTrials.gov

Other trials for Rare hereditary hemochromatosis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT05294471
Fully Automated High-Throughput Quantitative MRI of the Liver
University of Wisconsin, Madison

See all trials for Rare hereditary hemochromatosis →

← Back to all trials